Gilead Sciences Inc. (GILD)
NASDAQ · Healthcare
Gilead Sciences Inc. Long Term Debt 2007–2025
Gilead Sciences Inc. annual long term debt history from 2011 to 2025. Long term debt refers to financial obligations that are due more than one year in the future.
- Gilead Sciences Inc. long term debt as of December 31, 2025: 24.94B, a 6.64% decrease year-over-year.
- Gilead Sciences Inc. long term debt for 2025 were 24.94B, a 6.64% decrease from 2024.
- Gilead Sciences Inc. long term debt for 2024 were 26.71B, a 6.90% increase from 2023.
- Gilead Sciences Inc. long term debt for 2023 were 24.99B, a 0.96% decrease from 2022.
- Gilead Sciences Inc. long term debt for 2022 were 25.23B.
Long Term Debt
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Gilead Sciences Inc. Annual Long Term Debt (Millions of US $) | |
|---|---|
| 2025 | $24,937 |
| 2024 | $26,710 |
| 2023 | $24,987 |
| 2022 | $25,229 |
| 2021 | $26,695 |
| 2020 | $31,402 |
| 2019 | $22,094 |
| 2018 | $24,574 |
| 2017 | $33,542 |
| 2016 | $26,346 |
| 2015 | $22,178 |
| 2014 | $12,404 |
| 2013 | $6,636 |
| 2012 | $8,224 |
| 2011 | $7,606 |
Gilead Sciences Inc. Long Term Debt — FAQ
Gilead Sciences Inc. (GILD) long term debt over the last 19 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GILD's long term debt history?
The chart and table above show Gilead Sciences Inc.'s long term debt by year and by quarter, including the growth rate.